|
| Sézary syndrome | 80 mg daily for 10–15 days and then 80 mg on alternate days for 1.5–23 weeks [4, 10, 16]
OR
125 mg/80 mg/80 mg for 3 days, in 2-week repetitions for 6–24 weeks [9] |
|
| Mycosis fungoides | 80 mg daily for 4 months or longer for prophylaxis [12]
OR
125 mg/80 mg/80 mg for 3 days, in 2-week repetitions for 6–24 weeks [9, 14] |
|
| Cutaneous anaplastic large cell lymphoma | 125 mg/80 mg/80 mg for 3 days [18] |
|
| Lung adenocarcinoma | 80 mg daily continuously for prophylaxis [8]
OR
125 mg/80 mg/80 mg for 3 days, then alternating days of 125 mg and 80 mg for 2 months or longer for prophylaxis [11] |
|
| Breast carcinoma | Day 1: 125 mg, day 3: 80 mg, day 5: 80 mg [7] |
|
| Metastatic solid tumors | Day 1: 125 mg, day 3: 80 mg, day 5: 80 mg [11] |
|
| Soft tissue sarcoma | Day 1: 125 mg, day 3: 80 mg, day 5: 80 mg [7] |
|
| Hodgkin’s lymphoma | 80 mg daily for 2 weeks [15] |
|
| Chronic kidney disease | 80 mg daily for 3–13 days [5] |
|
| Hyperuricemia | 80 mg daily for 3–13 days [5] |
|
| Iron deficiency | 80 mg daily for 3–13 days [5] |
|
| Pruritus of unclear origin | 125 mg on day 1, 80 mg on days 2–4 [17] |
|
| Brachioradial pruritus | 80 mg daily for 7 days; repeat if relapse [13] |
|
